Bromo-tris-pyrrolidino-phosphonium hexafluorophosphate, 99.0%, 5g

2-Chloro-6,7-dihydro-5H-cyclopenta[d]pyrimidine, 97.0%, 5g

N-[(11bS)-4,5-Dihydro-3H-dinaphtho[2,1-c:1',2'-e]azepin-2-yl]trifluoromethanesulfonamide>90.0%(HPLC)20mg

(5-(tert-butyl)-1,2,4-oxadiazol-3-yl)methanamine hydrochloride, 95.0%, 1g

1,3,2-Dioxathiolane 2-Oxide>98.0%(GC)25g

tert-Butyl 4-(ethylsulfonamido)piperidine-1-carboxylate, 95.0%, 1g

(1S,3R)-5-Bromo-3-hydroxy-2,3-dihydrospiro[indene-1,5'-oxazolidine]-2',4'-dione, 97%, 100mg

Dodecylmethylsiloxane-hydroxypolylalkyleneoxypropylmethylsiloxane, copolymer cSt 1000-4000, 100g

1-(3-Methoxyphenyl)cyclobutan-1-amine hydrochloride, 95.0%, 1g

4-ethyl-4H-1,2,4-triazole-3-thiol, 95.0%, 250mg

4-(1,3-Benzothiazol-2-yl)aniline, 97.0%, 1g

4-pentylbenzoyl chloride, 95.0%, 1g

4-Oxazolecarboxylic Acid>98.0%(GC)(T)1g